elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48272510-2669DAEA-F5AA-4386-BB1A-689D784A300C
Q48272510-2669DAEA-F5AA-4386-BB1A-689D784A300C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48272510-2669DAEA-F5AA-4386-BB1A-689D784A300C
Residual disease detection using targeted parallel sequencing predicts relapse in cytogenetically normal acute myeloid leukemia.
P2860
Q48272510-2669DAEA-F5AA-4386-BB1A-689D784A300C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48272510-2669DAEA-F5AA-4386-BB1A-689D784A300C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1b137b696cfc382bccb8c784909972b608713929
P2860
Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease.